跳至主要内容
临床试验/NCT02570360
NCT02570360已完成不适用

Comparative Effects of Exercise and Treatment-as-usual on Abstinence, Craving, and the Endocannabinoid System in Substance Users

University of Wisconsin, Madison2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
2
主要终点
Withdrawal Checklist: Change in physical and psychological withdrawal symptoms over the course of the intervention

研究概览

简要总结

The research study compares the substance abuse treatment outcomes (e.g., craving, withdrawal symptoms, rates of use, abstinence) of standard intensive outpatient care, with or without an added 6-wk aerobic exercise component. In addition, certain biomarkers associated with both exercise and substance use (e.g., endocannabinoids and cortisol) will be assessed. In a rolling admissions format over the course of a year, approximately 36 treatment-seeking substance users who are currently receiving Intensive Outpatient Treatment through a local Alcohol or Other Drug Abuse agency will be randomized to either receive 6 weeks aerobic exercise training in addition to standard care or standard care with 6 weekly laboratory visits to complete questionnaires (18 per group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Intact cognitive status and ability to provide informed consent
  • ability to read and write in English sufficient to provide consent and complete study questionnaires
  • current diagnosis of a single or of multiple substance use disorders
  • currently enrolled in an Intensive Outpatient Treatment substance use program
  • desire to quit and to seek treatment for substance use
  • currently sedentary, not participating in any formal/structured exercise program

排除标准

  • a history or present diagnosis of severe depression, psychotic, or bipolar disorder
  • presence of cardiac disease or any other medical condition that would make engaging in exercise unsafe
  • Undergoing methadone treatment
  • chronic conditions such as cancer, diabetes, kidney disease, or autoimmune disorders
  • women who are pregnant or planning to become pregnant

结局指标

主要结局

Withdrawal Checklist: Change in physical and psychological withdrawal symptoms over the course of the intervention

时间窗: up to 6 weeks

withdrawal symptoms will be assessed using the Withdrawal Checklist which asks participants to rate the severity of a variety physical and psychological symptoms over the past 48 hours. The total score on the Withdrawal Checklist will be used to provide an overall measured of withdrawal.

次要结局

  • change in cortisol concentrations(measured before and after sessions (via saliva swab) during the first, third, and sixth weeks of the 6-week intervention)
  • change in endocannabinoid concentrations(measured before and after sessions (via single venipuncture)during the first, third, and sixth weeks of the 6-week intervention)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验